FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/04/051578 [Registered on: 13/04/2023] Trial Registered Prospectively
Last Modified On: 12/04/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical study by using Kushthadi churna with Mustadi kwath in Prameha with special reference to hyperglycemia in Type 2 Diabetes melitus 
Scientific Title of Study   Open randomised controlled clinical study of efficacy of Kushthadi Churna(Harit samhita)with Mustadi kwath(Bhaishajya Ratnavali)in the clinical management of Prameha with special reference to hyperglycemia in Type 2 Diabetes melitus 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrPooja Satyanand Prabhu 
Designation  PG Scholar 
Affiliation  APMs Ayurved Mahavidyalay Sion 
Address  Kayachikitsa Department 4th floor,APMs Ayurved Mahavidyalay Sion

Mumbai
MAHARASHTRA
400022
India 
Phone  8692051424  
Fax    
Email  prabhupooja61996@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrAnaya Ashish Pathrikar 
Designation  HOD and guide 
Affiliation  APMs Ayurved Mahavidyalay Sion 
Address  Kayachikitsa Department 4th floor,APMs Ayurved Mahavidyalay Sion

Mumbai
MAHARASHTRA
400022
India 
Phone  9870214595  
Fax    
Email  anayapathrikar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrAnaya Ashish Pathrikar 
Designation  HOD and guide 
Affiliation  APMs Ayurved Mahavidyalay Sion 
Address  Kayachikitsa Department 4th floor,APMs Ayurved Mahavidyalay Sion

Mumbai
MAHARASHTRA
400022
India 
Phone  9870214595  
Fax    
Email  anayapathrikar@gmail.com  
 
Source of Monetary or Material Support  
APMs Ayurved Mahavidyalay Sion 
 
Primary Sponsor  
Name  Sheth RV Ayurvedic hospital and Sheth VM charitable dispensary 
Address  Kayachikitsa Department 4th floor,APMs Ayurved Mahavidyalay Sion 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrPooja Satyanand Prabhu  APMs Ayurved Mahavidyalay Sion  kayachikitsa department,4th floor,OPD no.9 & 10 Ayurved Mahavidyalay Sion, besides sion railway station, mumbai
Mumbai
MAHARASHTRA 
8692051424

prabhupooja61996@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ayurvidya Prasarak Mandal IEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: PRAMEHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Mustadi kwath, Reference: bhaishajya ratnavali, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -madhu), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: kushthadi churna, Reference: harit samhita, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -madhu), Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  BSL fasting ->110mg/dl to 180 mg/dl
post prandial->140mg/dl to 280 mg/dl 
 
ExclusionCriteria 
Details  patients on insulin therapy
patients with nephropathy,h/o diabetic keto acidosis,immunosuppressant drugs.
pregnant women and lactating mother 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To check for the symptomatic relief as per the gradation mentioned in subjective and objective criteria   15th day 30th day 45th day 60th day  
 
Secondary Outcome  
Outcome  TimePoints 
To check for the adverse drug effect of kushthadi churna   15th day ,30th day ,45th day ,60th day  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   22/04/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The prevalence rate of Diabetes has increased from 7.1% in 2009 to 8.4%in 2019. Ayurveda elaborated about Prameha in details classifying into 2 types -santarpanottha & apatarpanottha. Diabetes can be treated and its complications can be avoided or delayed with proper diet, physical activity, medication,regular screening and treatment. So work in ayurveda to search additional safe and effective treatment in Prameha(diabetes) is needed, along with Nidanparivarjan 
Close